نتایج جستجو برای: rifapentine polylactic acid

تعداد نتایج: 747691  

Journal: :Antimicrobial agents and chemotherapy 1999
T A Wichelhaus V Schäfer V Brade B Böddinghaus

Mutations of the rpoB gene conferring resistance to rifampin were analyzed in 40 methicillin-resistant Staphylococcus aureus isolates obtained from six countries. Interestingly, the majority of clinical isolates showed multiple mutations within rpoB. The amino acid substitution 481His-->Asn was the most prevalent one, capable of conferring low-level resistance on its own. Cross-resistance to ri...

Journal: :Journal of Nanomaterials 2022

Dural defect is a common problem in neurosurgery, and the emergence of expanded polytetrafluoroethylene material provides an effective solution for rehabilitation artificial blood vessels, heart patches, other fields. However, studies on repair dura have reported occurrence adverse events cerebrospinal fluid leakage. Therefore, task improving materials cannot be delayed. In this study, new comp...

2016
Yi-Wen Huang Shun-Fa Yang Yen-Po Yeh Thomas Chang-Yao Tsao Shih-Ming Tsao

Treatment of latent tuberculosis infection (LTBI) is essential for eradicating tuberculosis (TB). Moreover, the patient adherence is crucial in determining the effectiveness of TB control. Isoniazid given by DOTS daily for 9 months (9H) is the standard treatment for LTBI in Taiwan. However, the completion rate is low due to the long treatment period and its side effects. The combined regimen us...

Journal: :Advances in Materials Science and Engineering 2017

2016
Marcus B. Conde Fernanda C. Q. Mello Rafael Silva Duarte Solange C. Cavalcante Valeria Rolla Margareth Dalcolmo Carla Loredo Betina Durovni Derek T. Armstrong Anne Efron Grace L. Barnes Mark A. Marzinke Radojka M. Savic Kelly E. Dooley Silvia Cohn Lawrence H. Moulton Richard E. Chaisson Susan E. Dorman

BACKGROUND The combination of rifapentine and moxifloxacin administered daily with other anti-tuberculosis drugs is highly active in mouse models of tuberculosis chemotherapy. The objective of this phase 2 clinical trial was to determine the bactericidal activity, safety, and tolerability of a regimen comprised of rifapentine, moxifloxacin, isoniazid, and pyrazinamide administered daily during ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید